Artificial intelligence helps physicians better assess the effectiveness of bladder cancer treatment
In a small but multi-institutional study, an artificial intelligence-based system improved providers’ assessments of whether patients…
Browsing: Bladder Cancer
Lung cancer drug could improve survival rates for bladder cancer patients undergoing chemotherapy
Scientists from the University of Sheffield, UK, have discovered a drug already used to treat…
Therapeutically effective drugs identified for bladder cancer
Hundreds of chemical compounds were screened on cell cultures representing different stages and subtypes of…
NICE reverses recommendation allowing use of novel urothelial carcinoma immunotherapy on the NHS
Merck and Pfizer have announced that, following a successful appeal of the prior Final Appraisal…
Potential therapy may boost chemoimmunotherapy response in bladder cancer
Adding an anti-inflammatory medication to immunotherapy and standard chemotherapy drugs may provide long-term suppression of…
ASCO GU 2022: Enfortumab vedotin is effective in patients with aggressive bladder cancer
Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in…
ASCO GU 2022: Biomarker may help predict survival in patients with bladder cancer
Long-term survival data from the first prospective, randomized biomarker validation trial in patients with muscle-invasive…
Novel drug liberates tumour vessels to aid cancer drug delivery
A therapeutic antibody developed by scientists at UCL, USA, has been shown to unblock and…
AUA 2021: Researchers find early stage micropapillary bladder cancer outcomes similar to late-stage conventional urothelial carcinoma
A recent study from Fox Chase Cancer Center has found that in patients treated with…
Study suggests adding the drug berzosertib to standard treatment for metastatic bladder cancer does not benefit patients
A Phase 2 trial led by City of Hope, USA, suggests that adding the novel…